查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1807720

皮下免疫球蛋白的全球市场:市场规模·占有率·趋势，产业分析 (各产品·各用途·各最终用途·各地区)，2025～2034年的市场预测

Subcutaneous Immunoglobulin Market Size, Share, Trends, & Industry Analysis Report By Product (IgG, IgA, and IgM), By Application, By End Use, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 130 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，预计到 2034 年，皮下免疫球蛋白市场规模将达到 267.8 亿美元。本报告深入分析了当前的市场动态，并分析了未来的市场成长。

皮下免疫球蛋白 (SCIg) 是一种透过皮下注射的方式，用于输送抗体，帮助免疫缺陷症患者维持免疫系统稳定。由于 SCIg 为患者提供的便利性和自主性，越来越多的患者选择在家治疗，因此市场正在不断扩大。与需要住院输液不同，SCIg 允许在患者熟悉的环境中接受治疗，从而减轻了患者频繁就诊的负担。这种灵活性提高了治疗依从性、患者整体满意度和生活质量，巩固了脊髓免疫球蛋白 (SCIg) 作为首选免疫球蛋白疗法的地位。

皮下免疫球蛋白市场受到输送设备和输注技术的持续创新的进一步推动。便携式帮浦和预充式註射器等使用者友善系统的开发简化了给药流程，使更广泛的患者群体更容易获得治疗。这些进步降低了治疗的复杂性和时间，最大限度地减少了应用障碍。技术进步，尤其是脊髓免疫球蛋白 (SCIg) 的进步，正在扩大治疗范围，并满足日益增长的便利性和高效性需求，从而增强了脊髓免疫球蛋白在长期免疫治疗管理中的地位。

皮下免疫球蛋白市场：分析概论

按产品划分，预计 IgG 将在 2024 年占市场收入占有率的主导地位。这是因为 IgG 是主要的免疫球蛋白同型，可有效治疗多种原发性和继发性免疫缺陷。

按应用划分，全球范围内癌症和自体免疫疾病等可导致获得性免疫缺陷的疾病的增加，正在推动继发性免疫缺陷领域的增长。

由于成熟的医疗保健体系和先进的治疗方案的快速整合，北美在 2024 年引领了全球皮下免疫球蛋白市场。

预计亚太地区将实现最高成长率，这得益于大规模的医疗保健投资、疾病意识的提高以及最新治疗方法的可及性改善。

全球主要公司包括 Baxter、Biotest、CSL Behring、GC Biopharma USA, Inc.、Grifols、Kamada Ltd.、LFB、Nufactor、Octapharma 和 Takeda Pharmaceuticals。

目录

第1章 简介

第2章 摘要整理

第3章 分析方法

第4章 全球皮下免疫球蛋白市场洞察

  • 市场概述
  • 皮下免疫球蛋白的市场动态
    • 促进因素和机会
      • 免疫缺陷疾病盛行率不断上升
      • 製剂技术的进步
    • 阻碍因素与课题
      • 高额的治疗成本
  • 大环境分析
  • 皮下免疫球蛋白市场趋势
  • 价值链分析

第5章 皮下免疫球蛋白市场:各产品种类

  • 主要调查结果
  • 简介
  • IgG
  • IgA
  • IgM

第6章 皮下免疫球蛋白市场:各用途

  • 主要调查结果
  • 简介
  • 原发性免疫缺陷症
  • 次发性免疫力缺乏症

第7章 皮下免疫球蛋白市场:各最终用途

  • 主要调查结果
  • 简介
  • 医院
  • 居家医疗
  • 诊疗所
  • 其他

第8章 皮下免疫球蛋白市场:各地区

  • 主要的分析结果
  • 简介
    • 皮下免疫球蛋白市场分析:各地区 (2020～2034年)
  • 北美
    • 北美:各产品种类，各地区(2020～2034年)
    • 北美:各用途，各地区(2020～2034年)
    • 北美:各最终用途，各地区(2020～2034年)
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各产品种类，各地区(2020～2034年)
    • 欧洲:各用途，各地区(2020～2034年)
    • 欧洲:各最终用途，各地区(2020～2034年)
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各产品种类，各地区(2020～2034年)
    • 亚太地区:各用途，各地区(2020～2034年)
    • 亚太地区:各最终用途，各地区(2020～2034年)
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各产品种类，各地区(2020～2034年)
    • 中东·非洲:各用途，各地区(2020～2034年)
    • 中东·非洲:各最终用途，各地区(2020～2034年)
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东·非洲
  • 南美
    • 南美:各产品种类，各地区(2020～2034年)
    • 南美:各用途，各地区(2020～2034年)
    • 南美:各最终用途，各地区(2020～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第9章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第10章 企业简介

  • Baxter
  • Biotest
  • CSL Behring
  • GC Biopharma USA, Inc.
  • Grifols
  • Kamada Ltd.
  • LFB
  • Nufactor
  • Octapharma
  • Takeda
Product Code: PM4416

The subcutaneous immunoglobulin market size is expected to reach USD 26.78 billion by 2034, according to a new study by Polaris Market Research. The report "Subcutaneous Immunoglobulin Market Share, Size, Trends, Industry Analysis Report: By Product (IgG, IgA, and IgM), By Application, By End Use, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Subcutaneous immunoglobulin (SCIg) is a therapy administered under the skin to deliver antibodies that help maintain immune system stability in patients with immunodeficiency disorders. This market is witnessing expansion due to the growing shift toward home-based treatments, driven by the convenience and autonomy that SCIg offers patients. Unlike hospital-dependent infusions, SCIg enables individuals to manage their therapy in familiar settings, reducing the burden of frequent clinical visits. This flexibility improves treatment adherence and also enhances overall patient satisfaction and quality of life, reinforcing SCIg's role as a preferred mode of immunoglobulin therapy.

The subcutaneous immunoglobulin market is further driven by the continuous innovation in delivery devices and infusion technologies. The development of user-friendly systems, such as portable pumps and pre-filled syringes, is simplifying the administration process and making therapy more accessible to a wider patient base. These advancements reduce the complexity and time associated with treatment, minimizing barriers to adoption. Technological progress is especially expanding the therapeutic reach of SCIg and strengthening its presence in long-term immunotherapy management by aligning with the growing demand for convenience and efficiency.

Subcutaneous Immunoglobulin Market Report Highlights

In terms of product, the IgG dominated the revenue share in 2024, as it is the primary immunoglobulin isotype used to effectively treat a wide range of primary and secondary immunodeficiency disorders.

Based on application, the secondary immunodeficiency segment growth is driven by the increasing global incidence of conditions like cancer and autoimmune diseases, which can cause acquired immune deficiencies.

North America led the global SCIG market in 2024, fueled by its refined healthcare systems and rapid integration of advanced therapeutic solutions.

Asia Pacific region is anticipated to register the highest growth rate, propelled by major healthcare investments, greater disease awareness, and improved access to modern treatments.

A few global key market players include Baxter; Biotest; CSL Behring; GC Biopharma USA, Inc.; Grifols; Kamada Ltd.; LFB; Nufactor; Octapharma; and Takeda.

Polaris Market Research has segmented the market report on the basis product type, application, end use, and region:

By Product Type Outlook (Revenue, USD Billion, 2020-2034)

IgG

IgA

IgM

By Application Outlook (Revenue, USD Billion, 2020-2034)

Primary Immunodeficiency Disease

Secondary Immunodeficiency Disease

By End Use (Revenue, USD Billion, 2020-2034)

Hospitals

Homecare

Clinics

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Subcutaneous Immunoglobulin Market Insights

  • 4.1. Subcutaneous Immunoglobulin Market - Market Snapshot
  • 4.2. Subcutaneous Immunoglobulin Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growth in Prevalence of Immunodeficiency Diseases
      • 4.2.1.2. Rising Advancement in Formulation Technology
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Treatment Cost
    • 4.2.3. Public opinion and privacy legal precedents
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Subcutaneous Immunoglobulin Market Trends
  • 4.6. Value Chain Analysis

5. Subcutaneous Immunoglobulin Market, By Product Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Subcutaneous Immunoglobulin Market, By Product Type, by Region, 2020-2034 (USD Billion)
  • 5.3. IgG
    • 5.3.1. Subcutaneous Immunoglobulin Market, by IgG, by Region, 2020-2034 (USD Billion)
  • 5.4. IgA
    • 5.4.1. Subcutaneous Immunoglobulin Market, by IgA, by Region, 2020-2034 (USD Billion)
  • 5.5. IgM
    • 5.5.1. Subcutaneous Immunoglobulin Market, by IgM, by Region, 2020-2034 (USD Billion)

6. Subcutaneous Immunoglobulin Market, By Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Subcutaneous Immunoglobulin Market, By Application, by Region, 2020-2034 (USD Billion)
  • 6.3. Primary Immunodeficiency Disease
    • 6.3.1. Subcutaneous Immunoglobulin Market, by Primary Immunodeficiency Disease, by Region, 2020-2034 (USD Billion)
  • 6.4. Secondary Immunodeficiency Disease
    • 6.4.1. Subcutaneous Immunoglobulin Market, by Secondary Immunodeficiency Disease, by Region, 2020-2034 (USD Billion)

7. Subcutaneous Immunoglobulin Market, By End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Subcutaneous Immunoglobulin Market, By End Use, by Region, 2020-2034 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Subcutaneous Immunoglobulin Market, by Hospitals, by Region, 2020-2034 (USD Billion)
  • 7.4. Homecare
    • 7.4.1. Subcutaneous Immunoglobulin Market, by Homecare, by Region, 2020-2034 (USD Billion)
  • 7.5. Clinics
    • 7.5.1. Subcutaneous Immunoglobulin Market, by Clinics, by Region, 2020-2034 (USD Billion)
  • 7.6. Others
    • 7.6.1. Subcutaneous Immunoglobulin Market, by Others, by Region, 2020-2034 (USD Billion)

8. Subcutaneous Immunoglobulin Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Subcutaneous Immunoglobulin Market Assessment, By Geography, by Region, 2020-2034 (USD Billion)
  • 8.3. Subcutaneous Immunoglobulin Market - North America
    • 8.3.1. North America: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
    • 8.3.2. North America: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
    • 8.3.3. North America: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
    • 8.3.4. Subcutaneous Immunoglobulin Market - US
      • 8.3.4.1. US: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
      • 8.3.4.2. US: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
      • 8.3.4.3. US: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
    • 8.3.5. Subcutaneous Immunoglobulin Market - Canada
      • 8.3.5.1. Canada: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • 8.4. Subcutaneous Immunoglobulin Market - Europe
    • 8.4.1. Europe: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
    • 8.4.4. Subcutaneous Immunoglobulin Market - UK
      • 8.4.4.1. UK: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
    • 8.4.5. Subcutaneous Immunoglobulin Market - France
      • 8.4.5.1. France: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
    • 8.4.6. Subcutaneous Immunoglobulin Market - Germany
      • 8.4.6.1. Germany: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
    • 8.4.7. Subcutaneous Immunoglobulin Market - Italy
      • 8.4.7.1. Italy: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
    • 8.4.8. Subcutaneous Immunoglobulin Market - Spain
      • 8.4.8.1. Spain: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
    • 8.4.9. Subcutaneous Immunoglobulin Market - Netherlands
      • 8.4.9.1. Netherlands: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
    • 8.4.10. Subcutaneous Immunoglobulin Market - Russia
      • 8.4.10.1. Russia: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
    • 8.4.11. Subcutaneous Immunoglobulin Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • 8.5. Subcutaneous Immunoglobulin Market - Asia Pacific
    • 8.5.1. Asia Pacific: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
    • 8.5.4. Subcutaneous Immunoglobulin Market - China
      • 8.5.4.1. China: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
    • 8.5.5. Subcutaneous Immunoglobulin Market - India
      • 8.5.5.1. India: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
    • 8.5.6. Subcutaneous Immunoglobulin Market - Malaysia
      • 8.5.6.1. Malaysia: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
    • 8.5.7. Subcutaneous Immunoglobulin Market - Japan
      • 8.5.7.1. Japan: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
    • 8.5.8. Subcutaneous Immunoglobulin Market - Indonesia
      • 8.5.8.1. Indonesia: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
    • 8.5.9. Subcutaneous Immunoglobulin Market - South Korea
      • 8.5.9.1. South Korea: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
    • 8.5.10. Subcutaneous Immunoglobulin Market - Australia
      • 8.5.10.1. Australia: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
    • 8.5.11. Subcutaneous Immunoglobulin Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • 8.6. Subcutaneous Immunoglobulin Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
    • 8.6.4. Subcutaneous Immunoglobulin Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
    • 8.6.5. Subcutaneous Immunoglobulin Market - UAE
      • 8.6.5.1. UAE: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
    • 8.6.6. Subcutaneous Immunoglobulin Market - Israel
      • 8.6.6.1. Israel: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
    • 8.6.7. Subcutaneous Immunoglobulin Market - South Africa
      • 8.6.7.1. South Africa: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
    • 8.6.8. Subcutaneous Immunoglobulin Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • 8.7. Subcutaneous Immunoglobulin Market - Latin America
    • 8.7.1. Latin America: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
    • 8.7.4. Subcutaneous Immunoglobulin Market - Mexico
      • 8.7.4.1. Mexico: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
    • 8.7.5. Subcutaneous Immunoglobulin Market - Brazil
      • 8.7.5.1. Brazil: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
    • 8.7.6. Subcutaneous Immunoglobulin Market - Argentina
      • 8.7.6.1. Argentina: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
    • 8.7.7. Subcutaneous Immunoglobulin Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Baxter
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Biotest
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. CSL Behring
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. GC Biopharma USA, Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Grifols
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Kamada Ltd.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. LFB
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Nufactor
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Octapharma
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Takeda
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables:

  • Table 1 Global Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 2 Global Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 3 Global Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 4 North America: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 5 North America: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 6 North America: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 7 US: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 8 US: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 9 US: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 10 Canada: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 11 Canada: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 12 Canada: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 13 Europe: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 14 Europe: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 15 Europe: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 16 UK: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 17 UK: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 18 UK: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 19 France: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 20 France: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 21 France: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 22 Germany: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 23 Germany: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 24 Germany: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 25 Italy: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 26 Italy: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 27 Italy: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 28 Spain: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 29 Spain: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 30 Spain: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 34 Russia: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 35 Russia: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 36 Russia: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 43 China: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 44 China: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 45 China: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 46 India: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 47 India: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 48 India: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 52 Japan: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 53 Japan: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 54 Japan: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 58 South Korea: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 59 South Korea: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 60 South Korea: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 61 Australia: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 62 Australia: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 63 Australia: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 73 UAE: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 74 UAE: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 75 UAE: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 76 Israel: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 77 Israel: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 78 Israel: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 79 South Africa: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 80 South Africa: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 81 South Africa: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 85 Latin America: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 86 Latin America: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 87 Latin America: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 88 Mexico: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 89 Mexico: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 90 Mexico: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 91 Brazil: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 92 Brazil: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 93 Brazil: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 94 Argentina: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 95 Argentina: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 96 Argentina: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Subcutaneous Immunoglobulin Market, by Product Type, by Region, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Subcutaneous Immunoglobulin Market, by Application, by Region, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Subcutaneous Immunoglobulin Market, by End Use, by Region, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Subcutaneous Immunoglobulin Market, by Region, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market By Product Type
  • Figure 7. Subcutaneous Immunoglobulin Market, By Product Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market By Application
  • Figure 9. Subcutaneous Immunoglobulin Market, By Application, 2024 & 2034 (USD Billion)
  • Figure 10. Market By End Use
  • Figure 11. Subcutaneous Immunoglobulin Market, By End Use, 2024 & 2034 (USD Billion)